Bone Biologics Stock (NASDAQ: BBLG) stock price, news, charts, stock research, profile.
You can purchase shares of Bone Biologics (NASDAQ:BBLG) through any online brokerage.
Other companies in Bone Biologics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
Bone Biologics has a consensus price target of $2.25.
The stock price for Bone Biologics (NASDAQ: BBLG) is $1.22 last updated November 12, 2024 at 7:56 PM EST.
There are no upcoming dividends for Bone Biologics.
Bone Biologics’s Q3 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for Bone Biologics.
Bone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.